Iovance's stock slides 40% after sharing data about its melanoma therapy - MarketWatch
5/26/2022 12:00:00 AM2 years 11 months ago
by Jaimy Lee
by Jaimy Lee
Shares of Iovance Biotherapeutics Inc. undefined tumbled about 40% in after-hours trading on Thursday. The company had announced new clinical data for its...
Shares of Iovance Biotherapeutics Inc. IOVA, +2.30% tumbled about 40% in after-hours trading on Thursday. The company had announced new clinical data for its experimental melanoma drug, includi… [+403 chars]
full article...